Mr. Goldby became Executive Chairman of Symyx in 2007. Before joining the company in 1998 as Chairman and Chief Executive Officer, Mr. Goldby served as Chief Executive Officer for more than ten years at MDL Information Systems, Inc., the enterprise software company that pioneered scientific information management. Earlier, Mr. Goldby held various management positions at ALZA Corporation, including President of Alza Pharmaceuticals. Mr. Goldby received a B.S. degree in chemistry from the University of North Carolina and a law degree from Georgetown University Law Center.
Isy Goldwasser was named Chief Executive Officer of Symyx Technologies, Inc. in 2007 and has served as President of Symyx since 1998. He became the first employee of Symyx Technologies in 1995 as Vice President, Corporate Development. Mr. Goldwasser is a named inventor on 28 U.S., European, German and Canadian patents. Mr. Goldwasser received his B.S. degree in Chemical Engineering from the Massachusetts Institute of Technology and his M.S. degree in Chemical Engineering from Stanford University.
Timothy Harkness has served as a Company director since 2008. Mr. Harkness is the President and Chief Executive Officer of Cell Biosciences, a private life sciences tools company focused on nano-proteomics. Mr. Harkness was formerly Senior Vice President and Chief Financial Officer at Nektar Therapeutics, Inc., a biopharmaceutical company. From 1998 through April 2007, Mr. Harkness served as Chief Financial Officer of Molecular Devices Corporation, an international life sciences tools company, which was acquired by Toronto-based MDS, Inc. Previously Mr. Harkness was in the health care investment banking group at Montgomery Securities and at Arthur Anderson. Mr. Harkness serves on the board of Cell Biosciences and fortéBio, a life sciences tools company. Mr. Harkness holds a BBA from University of Wisconsin and an MBA from Stanford University.
Dr. Hill has served since 2006 as President and Chief Executive Officer of Sun Chemical Corporation, a producer of printing inks and pigments, and also serves as a Supervisory Board member of Sun Chemical Group B.V. Prior to joining Sun Chemical Corporation in 2001, Dr. Hill spent four years at JM Huber Corporation as President of Engineered Materials. From 1980-1997, Dr. Hill served at AlliedSignal Inc., where his last position was President of Specialty Chemicals. Dr. Hill began his career at Union Carbide Corporation in 1970, and has also been Director of Exploratory and New Ventures Research at Occidental Petroleum Corporation. Dr. Hill holds a Ph.D. in Materials Science and Engineering as well as a M.S. in Engineering and a B.S. in Materials Science and Engineering from Massachusetts Institute of Technology.
From May of 2005 to May of 2007, Mr. Pasternack served as the President and Chief Executive Officer of Special Olympics, Inc., a global non-profit organization for athletes with intellectual disabilities. Prior to joining Special Olympics, Inc., Mr. Pasternack spent more than 28 years at Booz Allen Hamilton, Inc. where his last position was Senior Vice President and Managing Partner of its San Francisco office. He serves on the Boards of BEA Systems and Quantum Corp. and is a director at several non-profit organizations. Mr. Pasternack holds a B.E. from The Cooper Union and a M.S.E. from the University of Pennsylvania.
Mr. van Ingen recently retired from his position as president of the Bio-Analytical Measurement business of Agilent Technologies, Inc, a position he had held since May 2001. Prior to assuming that position, Mr. van Ingen held a number of positions in Agilent Technologies Chemical Analysis Group, including Vice President of Sales and Marketing from 1996 to April 2001, Americas Marketing Center Manager from 1989 to 1996, Product Marketing Manager at the Avondale Division from 1986 to 1989, and Business Development Manager at the Avondale Division from 1984 to 1986.
Stock transaction information provided by EDGAR Online. Symyx Technologies, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
= Chairman of the Board
= Chair 
= Member
= Independent Director
Chief Executive Officer